All
How Did I Lose My Convention Tax Deduction?
April 1st 2003Marge and Sam Smith, the hypothetical principals in a dermatology practice, recently returned from attending a meeting in another state. During the course of that three-day event, the Smiths made a lot of contacts, absorbed a number of great ideas, and even ordered a few things that they felt would benefit their dermatology practice.
Price Tag Holds Back Biologics for Psoriasis
April 1st 2003The use of biologics to treat psoriasis is on the move. A couple of systemic medications have received FDA approval for psoriasis and related conditions, and several more are in the pipeline. Although the drugs are reputed to cause fewer and less serious side effects than traditional psoriasis treatments, that doesn't mean side effects don't exist, and that makes them an issue for some doctors and patients alike.
Willing Providers, Unwilling Payers
April 1st 2003We have recently been in the extended process of recruiting a full-time clinical academician to staff busy resident-run clinics. While we wait for lightening to strike and successfully identify such an individual, several excellent community dermatologists, as a favor to our program, have volunteered to provide staff coverage until the position is filled.
Chronic Wound Strategy: Try and Try Again
April 1st 2003San Francisco -- It might not be the first, second, or even third treatment modality that is the charm for a chronic wound, but once the appropriate therapy is identified, the patient should have noticeable improvement within three to four weeks, Marketa Limova, M.D., said at the annual meeting of the American Academy of Dermatology.
P. Acnes Possible Factor in Rosacea
April 1st 2003San Francisco - Based on the theory that rosacea shares the same inflammatory features of acne, a recent study showed that, just as the combination of benzoyl peroxide 1 percent and clindamycin 5 percent gel is a powerful treatment modality for reducing Propionibacterium acnes levels, it also significantly reduces the papules and pustules of rosacea, according to Debra L. Breneman, M.D.
Taking HIV to HAART Hasn't Solved Zoster
April 1st 2003Boston - Herpes zoster infection rates in individuals living with HIV-1 infection have not improved since the availability of highly active antiretroviral therapy (HAART), according to research presented here at the Conference on Retroviruses and Opportunistic Infections.
Reducing Postherpetic Neuralgia
April 1st 2003Galveston, Texas - A recent analysis of data from an ongoing open-label trial provides strong validation of an earlier finding that adjunctive treatment of acute herpes zoster using the anticonvulsant drug gabapentin (Neurontin) dramatically reduces the incidence of postherpetic neuralgia, Mathijs H. Brentjens, M.D.